The African Friends of Sheba Mission to Israel
African Friends of Sheba Delegation Visited Israel
At the end of June, a unique delegation from the African Friends of Sheba arrived in Israel for a weeklong visit. During a tour of Sheba’s vast healthcare campus, the group had the chance to explore the transformative technologies of ARC, Sheba’s innovation center, and MSR – the national simulation center. In addition, the group learned about the ‘Gal’ workshop – a rehabilitation treatment program designed for IDF veterans and terror victims suffering from post-traumatic stress disorder (PTSD).
The annual Friends of Sheba Gala was among the trip’s highlights, and gave participants the opportunity to discover the remarkable stories of IDF veteran Itzik Saidyan, who made his first public appearance following a lengthy hospitalization for severe burns, a young IDF soldier who received an innovative jaw tumor treatment, and a 9-year-old girl who was able to resume her normal life following a complex heart transplant.
After their time at Sheba, the delegation traveled across Israel to visit Jerusalem, the Golan Heights, and even the Israel-Gaza border. Gaining a new perspective on Israel, and getting to know each other during an eye-opening experience, the mission was concluded in high spirits.
More Posts
Sheba Medical Center Join General Catalyst’s Health Assurance Ecosystem to Advance Innovative Medical Solutions
General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.
Revolutionizing Diagnostic Medicine: Sheba Partners with Aidoc for Early Intracerebral Hemorrhages Detection
A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.
Sheba and Vidac Pharma Partner to Overcome the Warburg Effect
CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.
